CALLIDA
DEAD

Serial Number

76466639

Owner

CALLIDA GENOMICS, INC.

Attorney

DONNA B. ROSE

Filing Date

Nov 14, 2002

Add to watchlist:

No watchlists yet
View on USPTO

CALLIDA Trademark

Serial Number: 76466639

CALLIDA is a trademark filed by CALLIDA GENOMICS, INC. on November 14, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

CALLIDA GENOMICS, INC. (3 trademarks)

670 ALMANOR AVENUE
SUNNYVALE, CA 94085

Entity Type: 03

Trademark Details

Filing Date

November 14, 2002

Registration Date

Not Registered

Published for Opposition

June 14, 2005

Goods & Services

Bioanalytical devices containing nucleic acid and other reagents for analysis of nucleic acids and proteins, namely, microarrays, microparticles, nano-particles, and microfluidic chips; laboratory equipment, namely DNA sequencers, DNA analyzers, DNA preparation and extraction instruments, and DNA hybridization instruments, for use in handling reagents, preparing nucleic acid samples and screening nucleic acid samples, and laboratory equipment, namely, nucleic acid synthesizers, nucleic acid cross-linking equipment, nucleic acid amplification apparatus, and microarray/biochip scanners and detectors, for use in detecting the presence of analytes in samples, identifying molecular information about the samples, and automating the assay processes; equipment for making molecular arrays, biochips and bioanalytical devices, namely, microarray spotters, microarray printers, and liquid and sample handling and pipetting instruments; computer software for the collection, analysis and management of nucleic acid data, protein data, chemical data and biological data for use in the field of scientific research and commercial development

Diagnostic medical reagents and compounds, namely, nucleic acids, amino acids, polypeptides, enzymes, antibodies, lipids, carbohydrates and serum; Diagnostic test and sample preparation kits for medical use comprised of chemical and biological reagents, nucleic acids, enzymes, reagents for analysis of nucleic acids and proteins, solid matrix materials, and consumables for laboratory use, namely, pipette tips, glass bottles, glass cover slips, glass slides, plastic tubes, plastic containers, tube racks; medical diagnostic test kits for detecting pathogens and analytes in organisms, including human, and in the environment

Chemical and biological reagents and compounds, namely, nucleic acids, amino acids, polypeptides, enzymes, antibodies, lipids, carbohydrates and serum for research and development, forensic or scientific use; test and sample preparation kits for scientific or forensic use comprised of chemical and biological reagents, nucleic acids, enzymes, solid matrix materials, and consumables for laboratory use, namely pipette tips, glass bottles, glass cover slips, glass slides, plastic tubes, plastic containers, and tube racks; test kits for detecting nucleic acids, sequences of nucleic acids, and proteins interacting with nucleic acids

Diagnostic, forensic and genetic medical testing services for others; providing databases of knowledge in the fields of genomics and genetics, namely, catalogs of gene sequences, sequence variations, genotypes, phenotypes and related chemical and biological data for medical use

Nucleic acid sample preparation, sequencing, genotyping and expression services for others; research and development services for others; research and development services for others in the fields of chemical or biological reagents, analytical devices, apparatus and instrument for use in product research and development, forensic analysis, medical diagnostics, separation and purification processes, environmental testing processes and industrial quality control processes; chemical screening analysis; providing databases of knowledge in the field of genomics and genetics, namely, catalogs of gene sequences, sequence variations, genotypes, phenotypes and related chemical and biological data for commercial use; licensing of intellectual property, namely technologies for analysis of nucleic acids and proteins, and knowledge databases for commercial and medical use

Filing History

UNDELIVERABLE MAIL - NO ACTION TAKEN
Jun 5, 2006 UNDN
PAPER RECEIVED
May 30, 2006 MAIL
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 8, 2006 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 8, 2006 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 6, 2005 NOAM
PUBLISHED FOR OPPOSITION
Jun 14, 2005 PUBO
NOTICE OF PUBLICATION
May 25, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 2, 2005 PREV
ASSIGNED TO LIE
Feb 18, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2005 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 9, 2005 XAEC
EXAMINERS AMENDMENT MAILED
Feb 9, 2005 CNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 8, 2005 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 13, 2004 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2004 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 18, 2004 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2004 TROA
CONTINUATION OF FINAL REFUSAL MAILED
Oct 20, 2004 CNCF
ACTION CONTINUING A FINAL - COMPLETED
Oct 19, 2004 CNCF
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2004 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 24, 2004 TROA
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
May 17, 2004 UNPR
FAX RECEIVED
May 17, 2004 FAXX
FINAL REFUSAL MAILED
Dec 3, 2003 CNFR
CASE FILE IN TICRS
Nov 4, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2003 CRFA
PAPER RECEIVED
Sep 12, 2003 MAIL
NON-FINAL ACTION MAILED
Mar 11, 2003 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2003 DOCK